Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emodepside vs Ivermectin for Strongyloidiasis
NCT06373835Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emodepside in strongyloidiasis, sponsored by Swiss Tropical and Public Health Institute. Started May 2024; status: completed.
02
Drugs
emodepside
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on NCT06373835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06373835.